Description
What is Mounjaro®? Mounjaro® is a breakthrough weight-management medication containing the active ingredient tirzepatide. It is the first treatment in a class known as dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonists. By mimicking both hormones, Mounjaro® regulates how your brain processes hunger, slows down stomach emptying, and lowers food cravings, enabling you to maintain a healthy calorie deficit.
Key Clinical Benefits:
-
Enhanced Weight Reduction: Clinical trials (SURMOUNT) demonstrate up to 22.5% body weight reduction over 72 weeks at higher maintenance doses.
-
Dual-Action Formula: Targets both GLP-1 and GIP receptors for broader appetite suppression.
-
Weekly Convenience: Administered once every 7 days using a multi-dose KwikPen®.
